Envoy Medical, Inc.
General ticker "COCH" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $79.0M (TTM average)
Envoy Medical, Inc. follows the US Stock Market performance with the rate: 4.2%.
Estimated limits based on current volatility of 2.6%: low 6.63$, high 6.99$
Factors to consider:
- Total employees count: 47 (+11.9%) as of 2025
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Market volatility, Failure to achieve profitability, Regulatory and compliance, Clinical trial failure, Inability to raise capital
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.32$, 14.49$]
- 2026-12-31 to 2027-12-31 estimated range: [3.08$, 10.69$]
Financial Metrics affecting the COCH estimates:
- Positive: with PPE of -5.6 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Operating cash flow
- Positive: -2.30 < Investing cash flow per share per price, % of -1.10
- Negative: Industry earnings per price (median), % of -1.21 <= 0
- Positive: Industry inventory ratio change (median), % of -0.23 <= 0
- Positive: Shareholder equity ratio, % of -142.07 <= 5.99
Short-term COCH quotes
Long-term COCH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.32MM | $0.23MM | $0.24MM |
| Operating Expenses | $18.69MM | $19.48MM | $22.51MM |
| Operating Income | $-18.37MM | $-19.26MM | $-22.27MM |
| Non-Operating Income | $-11.54MM | $-1.54MM | $-1.49MM |
| Interest Expense | $0.00MM | $0.82MM | $1.59MM |
| R&D Expense | $8.96MM | $10.18MM | $12.49MM |
| Income(Loss) | $-29.91MM | $-20.80MM | $-23.76MM |
| Net Income(Loss)* | $-29.91MM | $-20.80MM | $-23.76MM |
| Stockholders Equity | $-1.76MM | $-18.84MM | $-12.16MM |
| Inventory | $1.40MM | $1.71MM | $1.55MM |
| Assets | $7.64MM | $11.54MM | $8.56MM |
| Operating Cash Flow | $-17.65MM | $-17.95MM | $-18.20MM |
| Capital expenditure | $0.15MM | $0.98MM | $0.18MM |
| Investing Cash Flow | $-0.15MM | $-0.98MM | $-0.18MM |
| Financing Cash Flow | $21.84MM | $20.20MM | $16.63MM |
| Earnings Per Share** | $-23.83 | $-11.07 | $-10.21 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.